We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, James F. Morley is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2002 — 2004 |
Morley, James F |
F30Activity Code Description: Individual fellowships for predoctoral training which leads to the combined M.D./Ph.D. degrees. |
Polyglutamine Expansions and the Heat Shock Response @ Northwestern University
DESCRIPTION (provided by applicant): The folding and maintenance of proteins in their native conformation is an essential cellular process. Disruption of protein folding homeostasis, leading to protein aggregation, is associated with a variety of human diseases. A prototypical class of these disorders, comprised of eight neurodegenerative diseases including Huntington's Disease, is associated with genes encoding polyglutamine (polyQ) tracts in otherwise unrelated proteins. To investigate the principles underlying aggregation-related cellular dysfunction, we have used C. elegans expressing different lengths of polyQ as chimeric fusions to yellow fluorescent proteins. As C. elegans are transparent, this allows concurrent assessment of aggregate formation and toxicity in the same living animal. We have used this system to demonstrate protein aggregation and cellular toxicity, observed as a motility defect, upon expression of expanded polyQ. Further, we have used intermediate polyQ length (Q40) to demonstrate a direct role of aggregate formation in cellular dysfunction. In the proposed work we will use fluorescence recovery after photobleaching as a tool to investigate the biophysical properties of polyQ proteins in vivo and how this relates to the role of aggregate formation in cellular toxicity. We will use C. elegans lifespan mutants to investigate the relationship between aggregation, toxicity, and aging. Further using both forward and reverse genetic strategies, we will identify modifiers of the aggregation and toxicity phenotypes to expand the list of potential therapeutic targets for human proteinopathies and to further our understanding of how cells sense and adapt to the appearance of misfolded proteins.
|
1 |